Evidence map›Paper›PMID 42479149›Full record

ArticlePediatric nephrology (Berlin, Germany)2026

Impact of early volume expansion on severe long-term kidney sequelae in children with Shiga toxin-producing Escherichia coli hemolytic uremic syndrome.

Paula A Coccia, Laura F Alconcher, Alejandro Balestracci, Ana Paula Spizzirri, Laura A Garcia Chervo, Iliana Principi, Aida Vazquez, Flavia B Ramirez, Elsa M Isern, Mariana Saurit and 16 more

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Paula A CocciaDivision of Pediatric Nephrology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. paula.coccia@hospitalitaliano.org.ar.ORCID http://orcid.org/0000-0001-8615-6847
Laura F AlconcherPediatric Nephrology Unit, Hospital Interzonal General Dr. José Penna, Bahía Blanca, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0002-2130-0307
Alejandro BalestracciNephrology Unit, Hospital General de Niños Pedro de Elizalde, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0003-4083-2066
Ana Paula SpizzirriDepartment of Pediatric Nephrology, Hospital de Niños Sor María Ludovica, La Plata, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0002-4440-9567
Laura A Garcia ChervoDepartment of Nephrology, Hospital de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0001-8387-590X
Iliana PrincipiDepartment of Pediatric Nephrology, Hospital Pediátrico Humberto J Notti Mendoza, Mendoza, Argentina.ORCID http://orcid.org/0009-0007-7554-559X
Aida VazquezDepartment of Pediatric Nephrology, Hospital Municipal del Niño, San Justo, Buenos Aires, Argentina.
Flavia B RamirezPediatric Department, Hospital Provincial Dr. Castro Rendon, Neuquén, Argentina.ORCID http://orcid.org/0000-0002-8833-507X
Elsa M IsernDivision of Pediatric Nephrology, Hospital Nacional Profesor Dr. Alejandro Posadas, Buenos Aires, Argentina.ORCID http://orcid.org/0009-0008-1178-0475
Mariana SauritPediatric Nephrology Department, Hospital Materno Infantil, Salta, Argentina.
Gimena RamirezDepartment of Pediatric Nephrology, Hospital de Niños Dr. Ricardo Gutierrez, Buenos Aires, Argentina.
Maria Graciela Perez Y GutierrezPediatric Department, Sanatorio Güemes, Buenos Aires, Argentina.
Marta I GiordanoDepartment of Pediatrics, Complejo Sanitario San Luis, San Luis, Argentina.
Adriana AraldeDivision of Pediatric Nephrology, Hospital del Niño Jesús, San Miguel de Tucumán, Tucumán, Argentina.ORCID http://orcid.org/0000-0002-9144-2810
Veronica S SelvaDepartment of Pediatrics, Clinica Universitaria Reina Faviola, Córdoba, Argentina.
Nahir E QuijadaDivision of Pediatric Nephrology, Hospital Infantil Municipal, Córdoba, Argentina.
Jorge MonteroDepartment of Pediatric Nephrology, Hospital Materno Infantil de Mar del Plata, Buenos Aires, Argentina.
Andrea M ExeniDivision of Pediatric Nephrology, Hospital Austral, Pilar, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0003-1914-4103
Sabrina BronfenPediatric Nephrology Unit, Hospital Interzonal General Dr. José Penna, Bahía Blanca, Buenos Aires, Argentina.ORCID http://orcid.org/0009-0006-0686-3300
Romina S EscalanteDepartment of Pediatrics, Hospital Español Rosario, Santa Fe, Argentina.
María Carolina BettendorffPediatric Nephrology Unit, Sanatorio Allende, Córdoba, Argentina.
Diego B RipeauDepartment of Pediatrics, Sanatorio de La Trinidad de Palermo, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0002-1944-3608
Diana MassóDepartment of Pediatrics, Sanatorio de La Trinidad de Ramos Mejía, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0001-5765-0686
Viviana M RattoPediatric Department, Fundacion Hospitalaria, Buenos Aires, Argentina.
Cecilia CordobaPediatric Department, Sanatorio Güemes, Buenos Aires, Argentina.
Jose OjedaDepartment of Pediatrics, Hospital de La Madre y El Niño, La Rioja, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly fluid management may influence disease severity and long-term kidney outcomes in children with Shiga toxin-producing Escherichia coli hemolytic uremic syndrome (STEC-HUS). We evaluated the association between early volume expansion and severe long-term kidney sequelae.

methodsWe conducted a multicenter retrospective cohort study including children with STEC-HUS and severe acute kidney injury, defined by the need for dialysis for at least 48 h. Kidney outcome at follow-up was classified according to estimated glomerular filtration rate (GFR) as normal kidney function or chronic kidney disease stage 1 versus chronic kidney disease stages 2-5.

resultsA total of 232 children were included. Median age was 2.34 years (interquartile range 1.6-4). At the end of follow-up (median 4.8 years, interquartile range 3.2-6.6), 72 patients (31%) had kidney sequelae corresponding to chronic kidney disease stages 2-5. Early volume expansion was performed in 102 patients (44%). These patients required dialysis for a shorter duration, had higher estimated GFR at follow-up, and less frequently developed chronic kidney disease stages 2-5. Lack of early volume expansion was independently associated with higher odds of kidney sequelae (odds ratio 2.46, 95% confidence interval 1.25-5.03), as was longer dialysis duration (odds ratio 1.10 per day, 95% confidence interval 1.05-1.15). Estimated GFR at follow-up was inversely correlated with dialysis duration; this association was not evident in patients who received early volume expansion but remained significant in those who did not.

conclusionsEarly volume expansion and shorter dialysis duration were associated with long-term improved kidney outcomes.

Indexed as

Chronic kidney diseaseHemolytic uremic syndromeKidney replacement therapyKidney sequelaeShiga toxin-producing Escherichia coliVolume expansion

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.